Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.98.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.98.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.13.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.13.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.34.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.34.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.124.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.124.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.161NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.177.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.121NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.121NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AS.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.115NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.115NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.127.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.127.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.88NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.88NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.519NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.519NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.514NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.514NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.87NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.87NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAPNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAPNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used